Parkinson’s Disease – Drug Pipeline Analysis and Market Forecasts to 2015

Summary

Parkinson’s Disease – Drug Pipeline Analysis and Market Forecasts to 2015 is an essential source of information and analysis on the global Parkinson’s disease market. The report identifies the key trends shaping and driving the global Parkinson’s disease market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global Parkinson’s disease sector.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by team of industry experts.

Scope

The scope of the report includes:
– Annualized global Parkinson’s disease market revenues data from 2000 to 2008, forecast forward for 7 years to 2015.
– Geographies covered in this report include the US, the UK, Italy, Spain, Germany, France, and Japan.
– Pipeline analysis data providing a split across different phases, mechanism of action being developed and emerging trends. Key classes of mechanism of action includes dopamine agonists, adenosine receptor antagonists, serotonin receptor targetters, glutamate receptor antagonists, NMDA receptor targetters, AMPA receptor antagonists, stem cell and gene therapy.
– Analysis of the current and future market competition in the global Parkinson’s disease market. Key future market players covered are Merck Serono, Acadia Pharmaceuticals, Axxonis Pharma AG, Avicena Group Inc., and Solvay Pharmaceuticals.
– Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
– Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for future market associated with Parkinson’s disease.

Reasons to buy

The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:
– Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.
– Develop business strategies by understanding the trends shaping and driving the global Parkinson’s disease market.
– Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global Parkinson’s disease market in future.
– Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
– Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
– What’s the next big thing in the global Parkinson’s disease market landscape? – Identify, understand and capitalize.

Click for report details: www.companiesandmarkets.com/Summary-Market-Report/parkinsons-dis ..

 

 

 

 

 

 

 

 

 

 


  This content has been Digiproved

Advertisements
This entry was posted in Healthcare. Bookmark the permalink.

2 Responses to Parkinson’s Disease – Drug Pipeline Analysis and Market Forecasts to 2015

  1. Pingback: I’ll MAKE Me Some PD Awareness! | My Parkinson's Diary

  2. Pingback: Parky Headlines, April 23, 2010 | My Parkinson's Diary

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s